Skip to main content

Table 2 Percentages of the most frequent and selected general adverse events reported for different long-acting antipsychotic drugs

From: Long-acting antipsychotic drugs for the treatment of schizophrenia: use in daily practice from naturalistic observations

Drug

FL

R

R

R

R, in no r

R in r

R

R vs oral

R

R

R y

R a

R

R

R

R

V

Z

Reference

[131]

[15]

[79]

[86]

[84]

[84]

[85]

[88]

[89]

[90]

[91]

[91]

[105]

[107]

[132]

[133]

[88]

[76]

n

16

715

192

202

312

82

1476

100

40

249

66

351

336

725

87

529

565

19

Anxiety

12.5

12

12

15

28.7

24.5

6.9

11.0

---

11

21

23

22.3

26

16.1

23.9

---

---

Insomnia

6.2

10

9

9

26.5

25.0

7.0

9.0

5.0

6

29

19

23.5

22

16.1

18.7

---

8

Disease exacerbation

---

---

10

---

20.1

15.8

6.1

5.0

---

6

12

12

18.2

15

19.5

7.4

---

---

Depressive reactions

17

---

6

---

19.8

15.7

---

5.0

---

---

17

14

19.3

15

---

11.3

---

25

Headache

---

---

---

---

14.7

14.7

---

---

2.5

6

21

11

 

---

11.5

7.7

---

---

GI symptomsa

---

---

---

---

---

---

---

---

---

---

11

3

---

---

---

---

---

17

Glucose-related AEs

---

---

---

0.5b

---

---

---

---

---

---

---

---

---

---

0.0

0.8c

0.0

---

Prolactin-related AEsd

---

---

---

0.5

---

---

---

6.0

2.5f

2.8

---

---

---

---

---

---

0.4e

---

Sedation/Somnolence

---

---

---

---

---

---

---

---

---

---

12

5

---

---

---

---

---

---

Rhinitis

---

---

---

---

---

---

---

---

---

---

18

11

---

---

---

---

---

---

Fatigue

---

---

---

---

---

---

---

---

---

---

15

7

---

---

---

---

---

---

Others

6.2h

---

---

---

---

---

---

---

2.5g,h

---

---

---

---

---

---

---

---

17h

  1. Abbreviations: FL = flupenthixol; R = risperidone; r = remission; y = in young patients; a = in adult patients; V = various; Z = zuclopenthixol decanoate; GI = gastrointestinal; AEs = adverse events; --- = not reported.
  2. aIncludes dyspepsia, nausea, and vomiting.
  3. bNew onset type 2 diabetes mellitus (n = 1).
  4. cNew onset type 2 diabetes mellitus (n = 3) and hyperglycemia (n = 1).
  5. dIncludes loss of libido, sexual impotence, galactorrhea, and gynecomastia.
  6. eImpotence (n = 1) and galactorrhea (n = 1).
  7. fIrregular menstruation (n = 1).
  8. gDisturbances in accommodation.
  9. hDizziness.